Treating Depression and Enhancing Locomotor Recovery Post-stroke

$194,349P20FY2018GMNIH

Medical University Of South Carolina, Charleston SC

Investigators

Linked publications & trials

Paper 39704676 Paper 39574865 Paper 39493729 Paper 39281864 Paper 39267797 Paper 39171205 Paper 39113593 Paper 39107522 Paper 38852541 Paper 38841121 Paper 38829110 Paper 38719432 Paper 38539642 Paper 38484654 Paper 38471802 Paper 38350038 Paper 38272665 Paper 38257646 Paper 38237508 Paper 38021221 Paper 37923642 Paper 37834116 Paper 37762933 Paper 37736398 Paper 37619892 Paper 37599440 Paper 37571837 Paper 37517466 Paper 37465999 Paper 37447958 Paper 37420566 Paper 37329979 Paper 37245692 Paper 37209010 Paper 37048684 Paper 37020411 Paper 36936523 Paper 36893382 Paper 36818163 Paper 36780248 Paper 36757086 Paper 36639543 Paper 36606675 Paper 36456037 Paper 36418438 Paper 36388195 Paper 36267328 Paper 36226541 Paper 36188979 Paper 36175848 Paper 36123170 Paper 36094287 Paper 36093716 Paper 36031059 Paper 36002874 Paper 35975361 Paper 35938072 Paper 35858266 Paper 35816982 Paper 35787816 Paper 35746940 Paper 35746934 Paper 35746927 Paper 35710678 Paper 35690092 Paper 35688299 Paper 35670017 Paper 35659252 Paper 35584925 Paper 35574963 Paper 35574460 Paper 35561963 Paper 35413931 Paper 35396067 Paper 35382902 Paper 35320135 Paper 35311412 Paper 35283994 Paper 35277444 Paper 35262808 Paper 35227927 Paper 35122483 Paper 35092839 Paper 35034757 Paper 35024536 Paper 35023218 Paper 34949592 Paper 34872927 Paper 34860349 Paper 34841963 Paper 34841125 Paper 34826801 Paper 34805997 Paper 34804258 Paper 34776421 Paper 34775141 Paper 34767967 Paper 34541374 Paper 34517143 Paper 34509909

Abstract

Depression is the most common neuropsychiatric manifestation following stroke and current treatments are largely ineffective. Depression has both direct and indirect effects on response to rehabilitation treatment; thus subjects with post-stroke depression (PSD) are routinely excluded from rehabilitation trials and treatment options for these individuals are extremely limited. We propose to determine the impact of two known anti-depressive treatments shown to be effective in non-stroke related depression - aerobic exercise training (AET) and repetitive transcranial magnetic stimulation (rTMS) - on post-stroke depressive symptoms. Further, we will determine if depression limits gains in walking function in response to treatment and if successful reduction in depressive symptoms facilitates improved walking. This project is based on the premise that depression negatively affects the potential for the brain to adapt in response to treatment such that rehabilitation may not produce the same brain changes that it does in non-depressed individuals. We propose that effective treatment for PSD would result in a virtuous cycle where reducing depression enhances brain changes, thereby facilitating functional gains. That is, effectively treating depression will make the brain better able to recover from stroke. Furthermore, in addition to its beneficial effects on depression, AET is known to improve post-stroke walking, thus providing an attractive option for treating depression as well as an established vehicle to study the effects of PSD on response to locomotor rehabilitation. The experiments proposed as part of this project are designed to address critical questions related to the: 1) effects of AET and/or rTMS on depressive symptoms; 2) potential for PSD to limit improvements in locomotor function; 3) impact of combining AET and rTMS treatments; and 4) relationship between baseline subject attributes and response to treatment(s). Successful completion of this project will provide a foundation for larger scale therapeutic trials to establish the effectiveness of AET and/or rTMS on post-stroke depression and walking as well as identify the mechanisms that may be responsible for the changes that occur in response to treatment.

View original record on NIH RePORTER →